The paediatric pCms market has been revitalised with the increasing demand for children's medication. Data from Menei.com shows that in 2023, the sales of paediatric pCms in China's three major terminals and six markets exceeded 18 billion yuan. In the brand TOP20 of public medical institutions, 12 exclusive varieties are on the list, and the 1.9 billion large varieties are in the first place; in the brand TOP20 of brick-and-mortar pharmacies, Longmu Strong Bone Pellets, Paediatric Black Bean and Ciao Clearing Heat Pellets, and Ding Gui Children's Navel Patch are in the top three, and Jianmin, Jichuan, and Sunflower are on the list.
In recent years, the paediatric proprietary medicine market has been revitalised with the increasing demand for children's medicines. Sales of paediatric proprietary Chinese medicines exceeded $18 billion, which has surpassed the pre-epidemic level and reached a record high.